1. Verstappen, C. C. P., Heimans, J. J., Hoekman, K., Postma, T. J. (2003). Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs, 63(15), 1549–1563.
2. Cavaletti, G., Marmiroli, P. (2010). Chemotherapy-induced peripheral neurotoxicity. Current Opinion in Neurology, 23(5), 566–575.
3. Gomber, S., Dewan, P., Chhonker, D. (2010). Vincristine induced neurotoxicity: Diagnosis and management. Indian Journal of Pediatrics, 77(6), 643–646.
4. Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S. Y., Friedlander, M. L., Kiernan, M. C. (2013). Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA: A Cancer Journal for Clinicians, 63(6), 419–437.
5. Verstappen, C. C. P., Postma, T. J., Hoekman, K., Heimans, J. J. (2005). Peripheral neuropathy due to chemotherapy: A review on the pathophysiology and therapeutic options. European Journal of Cancer, 41(3), 437–445.
6. Starobova, H., Vetter, I. (2017). Pathophysiology of chemotherapy-induced peripheral neuropathy. Frontiers in Molecular Neuroscience, 10, 174.
7. Windebank, A. J., Grisold, W. (2008). Chemotherapy-induced neuropathy. Journal of the Peripheral Nervous System, 13(1), 27–46.
8. Grisold, W., Cavaletti, G., Windebank, A. J. (2012). Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology, 14(suppl_4), iv45–iv54.